Lombard Odier Asset Management (Switzerland)’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-790,143
Closed -$3.03M 394
2023
Q1
$3.03M Sell
790,143
-146,358
-16% -$624K 0.26% 90
2022
Q4
$4.65M Hold
936,501
0.37% 67
2022
Q3
$4.48M Sell
936,501
-68,125
-7% -$359K 0.38% 62
2022
Q2
$4.52M Sell
1,004,626
-1,270,783
-56% -$5.52M 0.38% 66
2022
Q1
$10.8M Sell
2,275,409
-1,168,115
-34% -$6.47M 0.85% 44
2021
Q4
$25.6M Buy
3,443,524
+430,057
+14% +$2.67M 1.63% 21
2021
Q3
$17.1M Buy
3,013,467
+358,629
+14% +$2.07M 1.06% 40
2021
Q2
$17.5M Buy
2,654,838
+805,066
+44% +$5.62M 0.89% 48
2021
Q1
$15M Buy
+1,849,772
New +$15.1M 0.99% 40

Other funds holding IMGN

Lombard Odier Asset Management (Switzerland)'s IMGN Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 790,143 shares — an estimated $3.03M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in IMGN in Q1 2021 and held it in 9 quarters. The position peaked at $25.6M in Q4 2021. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 790,143 Immunogen Inc shares in Q2 2023, an estimated $3.03M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Immunogen Inc in Q1 2021 and held it in 9 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Immunogen Inc position peaked at $25.6M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.